We are live on ! Find out more
GX

Greylock XI Portfolio holdings

AUM $7.71M
1-Year Est. Return 28.23%
This Fund
S&P 500
This Quarter Est. Return
-24.32%
1 Year Est. Return
-28.23%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$491K
AUM Growth
-$157K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVEO
1
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$491K 100%
58,400
– –

Similar funds

CAU
Cambridge Associates (UK) Boston, Massachusetts $7.04M AUM 11.91% 1-Year Est. Return
SIPMI
Sterling Investment Partners Management II Westport, Connecticut $8.59M AUM 71.93% 1-Year Est. Return
CM
Cascabel Management New York $6.66M AUM 11.55% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return

Greylock XI's Q4 2014 Portfolio in Review

As of Q4 2014, Greylock XI held 1 position worth $491K, down 24% from $648K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2014: portfolio turnover was 0%. Greylock XI opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Greylock XI's ten largest holdings make up 100% of its $491K portfolio in Q4 2014.
  • Greylock XI opened 0 new positions and closed 0 in Q4 2014.
  • Greylock XI's portfolio value fell 24% quarter-over-quarter to $491K.

Based on Greylock XI's 13F filing for Q4 2014, filed 20 Jan 2015.